Smith & Nephew Past Earnings Performance
Past criteria checks 0/6
Smith & Nephew's earnings have been declining at an average annual rate of -17.1%, while the Medical Equipment industry saw earnings declining at 7.9% annually. Revenues have been growing at an average rate of 1.8% per year. Smith & Nephew's return on equity is 4.2%, and it has net margins of 4.1%.
Key information
-17.1%
Earnings growth rate
-17.2%
EPS growth rate
| Medical Equipment Industry Growth | -7.9% |
| Revenue growth rate | 1.8% |
| Return on equity | 4.2% |
| Net Margin | 4.1% |
| Next Earnings Update | 27 Feb 2024 |
Recent past performance updates
Recent updates
Smith & Nephew plc's (LON:SN.) Intrinsic Value Is Potentially 65% Above Its Share Price
Sep 11
Smith & Nephew (LON:SN.) Has A Pretty Healthy Balance Sheet
Aug 19Investors Could Be Concerned With Smith & Nephew's (LON:SN.) Returns On Capital
Jul 17Smith & Nephew plc (LON:SN.) Shares Could Be 22% Below Their Intrinsic Value Estimate
Jun 11Smith & Nephew (LON:SN.) Seems To Use Debt Quite Sensibly
May 09Smith & Nephew (LON:SN.) Will Want To Turn Around Its Return Trends
Apr 09Calculating The Intrinsic Value Of Smith & Nephew plc (LON:SN.)
Feb 09We Think Smith & Nephew (LON:SN.) Can Stay On Top Of Its Debt
Nov 21Returns On Capital Signal Tricky Times Ahead For Smith & Nephew (LON:SN.)
Nov 08Smith & Nephew plc's (LON:SN.) Intrinsic Value Is Potentially 99% Above Its Share Price
Oct 26These 4 Measures Indicate That Smith & Nephew (LON:SN.) Is Using Debt Reasonably Well
Aug 11There Are Reasons To Feel Uneasy About Smith & Nephew's (LON:SN.) Returns On Capital
Jul 28Smith & Nephew plc's (LON:SN.) Intrinsic Value Is Potentially 58% Above Its Share Price
Jun 26Some Investors May Be Worried About Smith & Nephew's (LON:SN.) Returns On Capital
Apr 29These 4 Measures Indicate That Smith & Nephew (LON:SN.) Is Using Debt Safely
Mar 26Earnings Beat: Smith & Nephew plc Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Feb 24Smith & Nephew's (LON:SN.) Returns On Capital Not Reflecting Well On The Business
Jan 25Are Investors Undervaluing Smith & Nephew plc (LON:SN.) By 30%?
Dec 02Smith & Nephew (LON:SN.) Might Be Having Difficulty Using Its Capital Effectively
Oct 23Smith & Nephew (LON:SN.) Could Easily Take On More Debt
Oct 09A Look At The Intrinsic Value Of Smith & Nephew plc (LON:SN.)
Aug 22Be Wary Of Smith & Nephew (LON:SN.) And Its Returns On Capital
Jun 09Smith & Nephew (LON:SN.) Has A Pretty Healthy Balance Sheet
May 25A Look At The Intrinsic Value Of Smith & Nephew plc (LON:SN.)
May 10Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 01 Jul 23 | 5,349 | 218 | 2,741 | 327 |
| 01 Apr 23 | 5,282 | 221 | 2,718 | 331 |
| 31 Dec 22 | 5,215 | 223 | 2,695 | 335 |
| 30 Sep 22 | 5,214 | 360 | 2,680 | 344 |
| 02 Jul 22 | 5,213 | 496 | 2,665 | 352 |
| 02 Apr 22 | 5,213 | 510 | 2,651 | 351 |
| 31 Dec 21 | 5,212 | 524 | 2,637 | 349 |
| 30 Sep 21 | 5,168 | 539 | 2,607 | 340 |
| 03 Jul 21 | 5,124 | 553 | 2,576 | 330 |
| 03 Apr 21 | 4,842 | 501 | 2,508 | 319 |
| 31 Dec 20 | 4,560 | 448 | 2,439 | 307 |
| 30 Sep 20 | 4,624 | 420 | 2,470 | 304 |
| 27 Jun 20 | 4,688 | 391 | 2,501 | 301 |
| 27 Mar 20 | 4,913 | 496 | 2,518 | 297 |
| 31 Dec 19 | 5,138 | 600 | 2,534 | 292 |
| 30 Sep 19 | 5,044 | 649 | 2,449 | 281 |
| 29 Jun 19 | 4,949 | 698 | 2,364 | 269 |
| 29 Mar 19 | 4,927 | 681 | 2,374 | 258 |
| 31 Dec 18 | 4,904 | 663 | 2,384 | 246 |
| 30 Sep 18 | 4,887 | 690 | 2,450 | 239 |
| 30 Jun 18 | 4,869 | 717 | 2,496 | 232 |
| 31 Mar 18 | 4,817 | 742 | 2,453 | 228 |
| 31 Dec 17 | 4,765 | 767 | 2,419 | 223 |
| 30 Sep 17 | 4,721 | 817 | 2,346 | 224 |
| 01 Jul 17 | 4,677 | 867 | 2,282 | 224 |
| 01 Apr 17 | 4,673 | 826 | 2,269 | 227 |
| 31 Dec 16 | 4,669 | 784 | 2,255 | 230 |
| 30 Sep 16 | 4,680 | 570 | 2,515 | 228 |
| 02 Jul 16 | 4,690 | 356 | 2,393 | 225 |
| 02 Apr 16 | 4,662 | 383 | 2,363 | 224 |
| 31 Dec 15 | 4,634 | 410 | 2,524 | 222 |
| 30 Sep 15 | 4,702 | 513 | 2,333 | 224 |
| 27 Jun 15 | 4,669 | 557 | 2,326 | 225 |
| 27 Mar 15 | 4,680 | 499 | 2,375 | 234 |
| 31 Dec 14 | 4,617 | 501 | 2,323 | 235 |
| 27 Sep 14 | 4,543 | 503 | 2,285 | 239 |
| 28 Jun 14 | 4,422 | 523 | 2,201 | 241 |
| 29 Mar 14 | 4,349 | 563 | 2,124 | 235 |
| 31 Dec 13 | 4,351 | 556 | 2,149 | 231 |
| 28 Sep 13 | 4,253 | 534 | 2,045 | 215 |
| 29 Jun 13 | 4,178 | 544 | 2,013 | 196 |
| 30 Mar 13 | 4,133 | 705 | 1,991 | 180 |
| 31 Dec 12 | 4,137 | 721 | 1,982 | 171 |
| 29 Sep 12 | 4,166 | 721 | 2,028 | 166 |
Quality Earnings: SN. has a large one-off loss of $224.0M impacting its last 12 months of financial results to December 19 55465.
Growing Profit Margin: SN.'s current net profit margins (4.1%) are lower than last year (9.5%).
Past Earnings Growth Analysis
Earnings Trend: SN.'s earnings have declined by 17.1% per year over the past 5 years.
Accelerating Growth: SN.'s has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: SN. had negative earnings growth (-56.1%) over the past year, making it difficult to compare to the Medical Equipment industry average (-34.1%).
Return on Equity
High ROE: SN.'s Return on Equity (4.2%) is considered low.